BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Achaogen Announces New Employment Inducement Grants - Nov. 27, 2017

  Each stock option has an exercise price per share equal to $11.89, which was the closing trading price on November 20, 2017.

  November 27, 2017

   · 

  1 min read
• New Intelligence Tool Helps Researchers Cope With Immuno-Oncology Boom

  IO Combination Trials Intelligence is part of Hanson Wade’s Beacon Targeted Therapies service.

  November 27, 2017

   · 

  1 min read
• Business

  Microbix Confirms Ramp-up of Production Bioreactor Capacity Increasing by 500%

  Microbix’s revenues are mainly from sales of its antigens as critical components for makers of tests that diagnose infectious diseases.

  November 27, 2017

   · 

  4 min read
• Business

  CDC Award Leidos Prime Contract

  The follow-on single-award time & materials contract has a one year-base period, four one-year options, and a total contract value of $26M.

  November 27, 2017

   · 

  2 min read
• BioMidwest

  Aratana Announces Proposed Public Offering

  Aratana Therapeutics today announced that it is commencing an underwritten registered public offering of $35,000,000 of shares of its common stock.

  November 27, 2017

   · 

  1 min read
• 

  FDA

  FDA Green Lights Apollo Endosurgery’s OverStitch Sx Endoscopic Suturing System

  OverStitch Sx removes this access limitation, and will be compatible with most single channel endoscopes with diameters ranging from 8.8 mm to 9.8 mm.

  November 27, 2017

   · 

  4 min read
• BioMidwest

  Medpace Holdings Announces Commencement of Proposed Secondary Offering of Common Stock by Selling Shareholder

  Jefferies LLC and Credit Suisse Securities (USA) LLC are acting as bookrunners for the offering.

  November 27, 2017

   · 

  2 min read
• Business

  Cambridge Epigenetix Appoints Professor Mark Dawson as Scientific Advisor

  The appointment further strengthens CEGX’s panel of opinion leaders providing expert advice across the Company’s key focus areas of epigenetics, oncology, liquid biopsy, diagnostic and therapeutic development.

  November 27, 2017

   · 

  2 min read
• BioMidwest

  Free Guides Help To Increase Food-Manufacturing Productivity and Compliance

  While manufacturers work to keep up with these changes, they must also continually optimize their equipment and processes to remain profitable.

  November 27, 2017

   · 

  1 min read
• Drug Development

  Regen BioPharma Begins in Vivo Assessment of Small Molecule Agonists to NR2F6 Nuclear Receptor

  Regen BioPharma has initiated in vivo and ex vivo assessments to determine the effects of some of the Company’s NR2F6 small molecule agonists in live rats and in tissues derived from humans and rats.

  November 27, 2017

   · 

  2 min read